In this month’s issue, Ethical Corporation Magazine debates whether increased transparency in healthcare is truly the best way to compel ethical behavior among industry players. In need of input from an expert on public health ethics, the publication asked Thought Leader Select’s Paul Meade to share his thoughts on the implications of expanding accountability in the pharmaceutical industry.
By Paul Meade, Patient Engagement Lead In 2022, there are hundreds of thousands of healthcare companies in the United States alone. With this level of
By Mark Schoeman, General Manager When you’re in the medical field, one of the key things you need to be thinking about is what your
By Paul Meade, Patient Engagement Lead It has become apparent that in order for a healthcare organization to succeed, they need to be able to
Mark Schoeman, General Manager at Clear Point Health talks about the ways in which the KOL/MSL engagement model is changing.
